Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers

Molecules

Volumn 19, Issue 2, 2014, Pages 2445-2457

  Chu, Yang ^a   Li, Dan ^b   Luo, Yi Fan ^a   He, Xiao Jin ^c   Jiang, Ming Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti HepG 2; Curcumin; Glycyrrhetinic acid; Nanostructured lipid carriers

Indexed keywords

CURCUMIN; DRUG CARRIER; GLYCYRRHETINIC ACID; LIPID; NANOMATERIAL;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; DRUG STABILITY; EVALUATION STUDY; HEPG2 CELL LINE; HUMAN; PARTICLE SIZE;

CELL PROLIFERATION; CURCUMIN; DRUG CARRIERS; DRUG STABILITY; GLYCYRRHETINIC ACID; HEP G2 CELLS; HUMANS; LIPIDS; NANOSTRUCTURES; PARTICLE SIZE;

EID: 84894630667     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19022445     Document Type: Article

References (29)

1. Yallapu, M.M.; Jaqqi, M.; Chauhan, S.C. Curcumin nanoformulationd: A future nanomedicine for cancer. Drug Discov. Today 2012, 17, 71-80.
2. Huang, M.T.; Newmark, H.L.; Frenkel, K. Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell. Biochem. Suppl. 1997, 27, 26-34.
3. Siddiqui, A.M.; Cui, X.; Wu, R.; Dong, W.; Zhou, M.; Hu, M.; Simms, H.H.; Wang, P. The antiinflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferatoractivated receptor-gamma. Crit. Care Med. 2006, 34, 1874-1882.
4. Kumar, K.; Rai. A.K. Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models. Pharmazie 2012, 67, 852-857.
5. Menon, V.P.; Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595, 105-125.
6. Paek, E.J.; Jeon, C.H.; Ko, G.; Kim, J.; Sohn, D.H. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol. 2000, 52, 437-440.
7. Ireson, C.R.; Jones, D.J.; Orr, S.; Coughtrie, M.W.; Boocock, D.J.; Williams, M.L.; Farmer, P.B.; Steward, W.P.; Gescher, A.J. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 105-111.
8. Maheshwari, R.K.; Singh, A.K.; Gaddipati. J.; Srimal, R.C. Multiple biological activities of curcumin: A short review. Life Sci. 2006, 78, 2081-2087.
9. Yang, C.L.; Liu, Y.Y.; Ma, Y.G.; Xue, Y.X.; Liu, D.G.; Ren, Y.; Liu, X.B.; Li, Y.; Li, Z. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 2012, 7, e37960.
10. Huang, M.T.; Smart, R.C.; Wong, C.Q.; Conney, A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-Otetradecanoylphorbol-13-acetate. Cancer Res. 1988, 48, 5941-5946.
11. Pereira, M.A.; Grubbs, C.J.; Barnes, L.H.; Li, H.; Olson, G.R.; Eto, I.; Juliana, M.; Whitaker, L.M.; Kelloff, G.J.; Steele, V.E.; et al. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7, 12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 1996, 17, 1305-1311.
12. Huang, M.T.; Loum Y.R.; Mam W.; Newmark, H.L.; Reuhl, K.R.; Conney, A.H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994, 54, 5841-5847.
13. Rao, C.V.; Rivenson, A.; Simi, B.; Reddy, B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995, 55, 259-266.
14. Zhang, F.; Altorki, N.K.; Mestre, J.R.; Subbaramaiah, K.; Dannenberg, A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999, 20, 445-451.
15. Wang, W.; Zhang, B.; Chen, H.; Zhang, L. Anticancer activities of curcum in on human hepatocarcinoma cell line Sk-hep-1. Zhongguo Zhong Yao Za Zhi 2010, 35, 485-488.
16. Churchill, M.; Chadburn, A.; Bilinski, R.T.; Bertagnolli, M.M. Inhibition of intestinal tumors by curcumin associated with changes in the intestinal immune cell profile. J. Surg. Res. 2000, 89, 169-175.
17. Muller, R.H.; Radtke. M.; Wissing, S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242, 121-128.
18. Jenning, V.; Thunemann, A.F.; Gohla, S.H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 2000, 199, 167-177.
19. Jenning, V.; Mader, K.; Gohla, S. Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: A 1H-NMR study. Int. J. Pharm. 2000, 205, 15-21.
20. Mehnert, W.; Mader, K. Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug. Deliv. Rev. 2001, 47, 165-196.
21. Muller, R.H.; Mader, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50, 161-177.
22. Muller, R.H.; Gohla, S.; Dingler, A.; Schneppe, T. Large Scale Production of Solid Lipid Nanoparticles (SLNTM) and Nanosuspensions (DissoCubesTM). In Handbook of Pharmaceutical Controlled Release Technology; Wise, D.L., Ed.; Marcel Dekker Inc: New York, NY, USA, 2000; pp. 359-376.
23. Uner, M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems. Pharmazie 2006, 61, 375-386.
24. Mao, S.J.; Hou, S.X.; He, R.; Zhang, L.K.; Wei, D.P.; Bi, Y.Q.; Jin, H. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J. Gastroenterol. 2005, 11, 3075-3079.
25. Lin, A.; Liu, Y.; Huang, Y.; Sun, J.; Wu, Z.; Zhang, X.; Ping, Q. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int. J. Pharm. 2008, 359, 247-253.
26. Mao, S.J.; Bi, Y.Q.; Jin, H.; Wei, D.P.; He, R.; Hou, S.X. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified withglycyrrhetinic acid. Pharmazie 2007, 62, 614-619.
27. Kato, K.; Uchida, E.; Kang, E.T.; Uyama, Y.; Ikada, Y. Polymer surface with graft chains. Prog. Polym. Sci. 2003, 28, 209-259.
28. Nam, H.Y.; Kwon, S.M.; Chung, H.; Lee, S.Y.; Kwon, S.H.; Jeon, H.; Kim, Y.; Park, J.H.; Kim, J.; Her, S.; et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 2009, 135, 259-267.
29. Zhou, L.L.; Wang, Y.; Liu, Q.F. Study on determination of entrapment efficiency of sinomenine liposomes. Zhongguo Zhong Yao Za Zhi 2006, 31, 731-734.